Learning Objectives: -Apply current guideline recommendations to differentiate among available treatment options for management of R/R CLL/SLL -Evaluate current evidence supporting the integration of novel therapies into clinical practice and optimal therapeutic sequencing for patients with R/R CLL/SLL -Implement current evidence supporting the integration of novel therapies into clinical practice and optimal therapeutic sequencing for patients with R/R CLL/SLL -Create individualized, evidence-based care plans through shared decision making to overcome barriers in therapeutic sequencing and maximizing the needs and preferences of patients with R/R CLL/SLL
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership · $19.99/mo
| Regular Membership | Free |
| Affiliated Health Professional Membership | Free |
| MENASA Group Explorer | Free |
| MENASA Group Elite Member | $19.99/mo |
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Neuroradiology
- Ophthalmology
- Patient Education & Health Literacy
- Pediatric Gastroenterology
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Thoracic Surgery
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Article / monograph / reference
- includes Microlearning
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedOct 31, 2025
-
Last day to claim creditOct 31, 2026 3 weeks left
-
Talem Health, LLC Navigating Resistance, Relapse, and Treatment Sequencing in Relapsed/Refractory CLL
-
Clinical Care Options, LLC (dba Decera Clinical Education) Global Perspectives on Sequencing Therapy in Relapsed/Refractory CLL
-
HealthTree Foundation for Chronic Lymphocytic Leukemia +1 Rethinking the CLL Treatment Sequence: Guidance on Selecting and Sequencing Modern Therapies for Sustained Efficacy Across Lines of Therapy
-
Blood Cancer United +1 A Discussion on Strategies for New Therapies and Evolving Care in Chronic Lymphocytic Leukemia (CLL)
-
Medical Learning Institute, Inc. A Community-Centered Approach to CELMoD Education in Relapsed/Refractory Multiple Myeloma
-
Medical Learning Institute, Inc. Expert Exchanges on the Evolving Treatment Landscape of Acute Lymphoblastic Leukemia
